AUH

AU RNA binding methylglutaconyl-CoA hydratase

Basic information

Region (hg38): 9:91213815-91361918

Links

ENSG00000148090NCBI:549OMIM:600529HGNC:890Uniprot:Q13825AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • 3-methylglutaconic aciduria type 1 (Definitive), mode of inheritance: AR
  • 3-methylglutaconic aciduria type 1 (Strong), mode of inheritance: AR
  • 3-methylglutaconic aciduria type 1 (Supportive), mode of inheritance: AR
  • 3-methylglutaconic aciduria type 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
3-methylglutaconic aciduria, type IARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Neurologic; Ophthalmologic720359; 3082934; 1710267; 1375542; 9762598; 10070612; 12434311; 15033206; 16354225; 17130438; 20855850; 21840233; 23296368
Dietary measures (leucine restriction) have been suggested

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the AUH gene.

  • 3-methylglutaconic aciduria type 1 (12 variants)
  • not provided (3 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the AUH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
2
clinvar
30
clinvar
1
clinvar
33
missense
1
clinvar
4
clinvar
85
clinvar
2
clinvar
1
clinvar
93
nonsense
2
clinvar
1
clinvar
1
clinvar
4
start loss
1
clinvar
1
frameshift
6
clinvar
1
clinvar
7
inframe indel
2
clinvar
2
splice donor/acceptor (+/-2bp)
4
clinvar
4
clinvar
8
splice region
6
9
3
18
non coding
8
clinvar
28
clinvar
13
clinvar
49
Total 13 10 99 60 15

Highest pathogenic variant AF is 0.000112

Variants in AUH

This is a list of pathogenic ClinVar variants found in the AUH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-91213916-G-A 3-methylglutaconic aciduria type 1 Uncertain significance (Jan 13, 2018)367471
9-91214085-GTAAA-G 3-methylglutaconic aciduria type 1 Uncertain significance (Jun 14, 2016)367472
9-91214111-C-T 3-methylglutaconic aciduria type 1 Uncertain significance (Jan 12, 2018)914654
9-91214128-ACT-A 3-methylglutaconic aciduria type 1 Uncertain significance (Jun 14, 2016)367473
9-91214148-T-C 3-methylglutaconic aciduria type 1 Benign (Jan 13, 2018)914655
9-91214173-C-T 3-methylglutaconic aciduria type 1 Uncertain significance (Jan 13, 2018)914656
9-91214241-T-C 3-methylglutaconic aciduria type 1 Benign (Jun 16, 2018)367474
9-91214288-C-T 3-methylglutaconic aciduria type 1 Uncertain significance (Jan 13, 2018)914657
9-91214319-C-T 3-methylglutaconic aciduria type 1 Uncertain significance (Jan 13, 2018)367475
9-91214364-C-T 3-methylglutaconic aciduria type 1 • Inborn genetic diseases Uncertain significance (Feb 15, 2023)444773
9-91214365-G-A 3-methylglutaconic aciduria type 1 • Inborn genetic diseases Uncertain significance (Sep 27, 2021)1358466
9-91214370-G-A 3-methylglutaconic aciduria type 1 Uncertain significance (Oct 03, 2023)1444069
9-91214371-G-T 3-methylglutaconic aciduria type 1 Uncertain significance (Aug 04, 2023)2166663
9-91214372-C-T 3-methylglutaconic aciduria type 1 Likely benign (Oct 13, 2023)2021678
9-91214377-T-A 3-methylglutaconic aciduria type 1 Uncertain significance (Dec 26, 2017)30081
9-91214388-G-C 3-methylglutaconic aciduria type 1 Uncertain significance (Jul 02, 2022)2141578
9-91214395-G-C 3-methylglutaconic aciduria type 1 • Inborn genetic diseases Uncertain significance (Sep 26, 2023)2145672
9-91214417-T-A 3-methylglutaconic aciduria type 1 • not specified Conflicting classifications of pathogenicity (Aug 16, 2022)367476
9-91214427-T-C 3-methylglutaconic aciduria type 1 • AUH-related disorder Pathogenic/Likely pathogenic (Dec 11, 2023)9060
9-91214430-GA-G 3-methylglutaconic aciduria type 1 Benign (Jul 29, 2021)1643925
9-91214431-A-G 3-methylglutaconic aciduria type 1 Benign (Dec 21, 2023)1594911
9-91214441-T-C 3-methylglutaconic aciduria type 1 Likely benign (Jun 09, 2022)2199609
9-91214646-GTTA-G Benign (Jul 15, 2018)1175398
9-91215824-T-C Likely benign (Dec 25, 2019)1207547
9-91216054-C-CA 3-methylglutaconic aciduria type 1 Uncertain significance (Apr 09, 2019)529798

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
AUHprotein_codingprotein_codingENST00000375731 10148099
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000008020.9241256840641257480.000255
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.3421691820.9290.000009522129
Missense in Polyphen6283.6150.7415927
Synonymous0.1966769.10.9700.00000390706
Loss of Function1.681118.90.5820.00000107217

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002310.000231
Ashkenazi Jewish0.0001040.0000992
East Asian0.0001630.000163
Finnish0.001020.00102
European (Non-Finnish)0.0001980.000193
Middle Eastern0.0001630.000163
South Asian0.0001960.000196
Other0.0003260.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the conversion of 3-methylglutaconyl-CoA to 3- hydroxy-3-methylglutaryl-CoA (PubMed:11738050, PubMed:12434311, PubMed:12655555). Also has itaconyl-CoA hydratase activity by converting itaconyl-CoA into citramalyl-CoA in the C5- dicarboxylate catabolism pathway (PubMed:29056341). The C5- dicarboxylate catabolism pathway is required to detoxify itaconate, a vitamin B12-poisoning metabolite (PubMed:29056341). Has very low enoyl-CoA hydratase activity (PubMed:7892223). Was originally identified as RNA-binding protein that binds in vitro to clustered 5'-AUUUA-3' motifs (PubMed:7892223). {ECO:0000269|PubMed:11738050, ECO:0000269|PubMed:12434311, ECO:0000269|PubMed:12655555, ECO:0000269|PubMed:7892223, ECO:0000303|PubMed:29056341}.;
Disease
DISEASE: 3-methylglutaconic aciduria 1 (MGA1) [MIM:250950]: An inborn error of leucine metabolism. It leads to an autosomal recessive syndrome with variable clinical phenotype, ranging from delayed speech development to severe psychomotor retardation, coma, failure to thrive, metabolic acidosis and dystonia. MGA1 can be distinguished from other forms of MGA by the pattern of metabolite excretion: 3-methylglutaconic acid levels are higher than those detected in other forms, whereas methylglutaric acid levels are usually only slightly elevated and there is a high level of 3-hydroxyisovaleric acid excretion (not present in other MGA forms). {ECO:0000269|PubMed:12655555}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Valine, leucine and isoleucine degradation - Homo sapiens (human);3-Methylglutaconic Aciduria Type I;Valine, Leucine and Isoleucine Degradation;2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency;Isovaleric Aciduria;3-Methylcrotonyl Coa Carboxylase Deficiency Type I;Propionic Acidemia;Maple Syrup Urine Disease;3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency;Isobutyryl-coa dehydrogenase deficiency;3-hydroxyisobutyric aciduria;3-hydroxyisobutyric acid dehydrogenase deficiency;Isovaleric acidemia;Methylmalonate Semialdehyde Dehydrogenase Deficiency;Methylmalonic Aciduria;3-Methylglutaconic Aciduria Type IV;3-Methylglutaconic Aciduria Type III;Beta-Ketothiolase Deficiency;Amino Acid metabolism;Branched-chain amino acid catabolism;Metabolism of amino acids and derivatives;leucine degradation;Metabolism;Valine, leucine and isoleucine degradation;Valine Leucine Isoleucine degradation (Consensus)

Recessive Scores

pRec
0.333

Intolerance Scores

loftool
0.801
rvis_EVS
-0.38
rvis_percentile_EVS
27.42

Haploinsufficiency Scores

pHI
0.131
hipred
N
hipred_score
0.331
ghis
0.529

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.770

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Auh
Phenotype

Zebrafish Information Network

Gene name
auh
Affected structure
leucine metabolic process
Phenotype tag
abnormal
Phenotype quality
disrupted

Gene ontology

Biological process
leucine catabolic process;fatty acid beta-oxidation;branched-chain amino acid catabolic process
Cellular component
mitochondrion;mitochondrial matrix
Molecular function
mRNA 3'-UTR binding;enoyl-CoA hydratase activity;methylglutaconyl-CoA hydratase activity;itaconyl-CoA hydratase activity